Similar Outcomes With Native Vitamin D and Eldecalcitol in Osteoporotic Women Taking Denosumab
How to Cite
OrthoEvidence. Similar Outcomes With Native Vitamin D and Eldecalcitol in Osteoporotic Women Taking Denosumab. ACE Report. 2020;9(11):30. Available from: https://myorthoevidence.com/AceReport/Report/12600
Comparison of the Effects of Native Vitamin D and Eldecalcitol on Muscular Strength and Dynamic Balance in Patients with Postmenopausal Osteoporosis.Prog Rehabil Med . 2020 Oct 30;5:20200026
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Thirty postmenopausal women with osteoporosis receiving denosumab treatment were randomized to receive either native vitamin D plus calcium supplementation or active Vitamin D3 (eldecalcitol). The outcomes of interest included muscle strength, static and dynamic postural balance, sitting balance, serum biochemical analyses (e.g. 25 hydroxyvitamin D, calcium, phosphorous, creatinine, blood urea nit...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE